m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00597
|
[1], [2], [3], [4], [5], [6] | |||
: m6A sites
Indirect
Enhancement
RNA modification
PTEN
PTEN
TET1
Demethylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC) | READER | |||
| m6A Target | microRNA 21 (MIR21) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> 5-methylcytidine (m5C) | ||||
| Epigenetic Regulator | Methylcytosine dioxygenase TET1 (TET1) | ERASER | View Details | ||
| Regulated Target | Mutated in multiple advanced cancers 1 (PTEN) | View Details | |||
| Crosstalk Relationship | m6A → m5C | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | HNRNPC interacts with microRNA 21 (MIR21), decreasing its m6A level and promoting its physical interaction with Mutated in multiple advanced cancers 1 (PTEN), which was regulated by TET1-mediated m5C modification. | ||||
In-vitro Model |
Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 | |
| Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | ||
| T98G | Glioblastoma | Homo sapiens | CVCL_0556 | ||
References
: m6A sites
: modification sites